SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Albers JM, Kuper HH, van Riel PL, Prevoo ML, van 't Hof MA, van Gestel AM, et al. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford) 1999; 38: 42330.
  • 2
    Backman CL. Employment and work disability in rheumatoid arthritis [review]. Curr Opin Rheumatol 2004; 16: 14852.
  • 3
    Boonen A, van der Heijde D, Landewe R, Guillemin F, Spoorenberg A, Schouten H, et al. Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis 2003; 62: 7417.
  • 4
    Chorus AM, Miedema HS, Wevers CJ, van der Linden S. Labour force participation among patients with rheumatoid arthritis. Ann Rheum Dis 2000; 59: 54954.
  • 5
    Chorus AM, Miedema HS, Boonen A, van der Linden S. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 2003; 62: 117884.
  • 6
    Lajas C, Abasolo L, Bellajdel B, Hernandez-Garcia C, Carmona L, Vargas E, et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 2003; 49: 6470.
  • 7
    Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004; 63: 395401.
  • 8
    Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001; 44: 52834.
  • 9
    Muchmore L, Lynch WD, Gardner HH, Williamson T, Burke T. Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers' compensation benefits cost and productivity loss of employers. J Occup Environ Med 2003; 45: 36978.
  • 10
    Sokka T, Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001; 28: 171822.
  • 11
    Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum 2004; 51: 48897.
  • 12
    Boonen A, van der Heijde D, Landewe R, Spoorenberg A, Schouten H, Rutten-van Molken M, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002; 61: 42937.
  • 13
    Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2000; 39: 2833.
  • 14
    De Buck PD, Schoones JW, Allaire SH, Vliet Vlieland TP. Vocational rehabilitation in patients with chronic rheumatic diseases: a systematic literature review. Semin Arthritis Rheum 2002; 32: 196203.
  • 15
    Eshoj P, Tarp U, Nielsen CV. Effect of early vocational intervention in a rheumatological outpatient clinic: a randomized study. Int J Rehabil Res 2001; 24: 2917.
  • 16
    Allaire SH, Li W, LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial. Arthritis Rheum 2003; 48: 32128.
  • 17
    De Buck PD, le Cessie S, van den Hout WB, Peeters AJ, Ronday HK, Westedt ML, et al. Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. Arthritis Rheum 2005; 53: 68290.
  • 18
    Crowther R, Marshall M, Bond G, Huxley P. Vocational rehabilitation for people with severe mental illness [review]. Cochrane Database Syst Rev 2001; CD003080.
  • 19
    Dixon L, Hoch JS, Clark R, Bebout R, Drake R, McHugo G, et al. Cost-effectiveness of two vocational rehabilitation programs for persons with severe mental illness. Psychiatr Serv 2002; 53: 111824.
  • 20
    Picard MH, Dennis C, Schwartz RG, Ahn DK, Kraemer HC, Berger WE 3rd, et al. Cost-benefit analysis of early return to work after uncomplicated acute myocardial infarction. Am J Cardiol 1989; 63: 130814.
  • 21
    Skouen JS, Grasdal AL, Haldorsen EM, Ursin H. Relative cost-effectiveness of extensive and light multidisciplinary treatment programs versus treatment as usual for patients with chronic low back pain on long-term sick leave: randomized controlled study. Spine 2002; 27: 9019.
  • 22
    De Buck PD, Breedveld J, van der Giesen FJ, Vlieland TP. A multidisciplinary job retention vocational rehabilitation programme for patients with chronic rheumatic diseases: patients' and occupational physicians' satisfaction. Ann Rheum Dis 2004; 63: 5628.
  • 23
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 24
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 25
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 3618.
  • 26
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 37383.
  • 27
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 28
    Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984; 3: 3059.
  • 29
    Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 36370.
  • 30
    Van den Berg B, Brouwer W, van Exel J, Koopmanschap M. Economic valuation of informal care: the contingent valuation method applied to informal caregiving. Health Econ 2005; 14: 16983.
  • 31
    Oostenbrink JB, Koopmanschap MA, Rutten FF. Manual for cost analyses, methods and standard prices for economic evaluations in health care. Amstelveen (Netherlands): Dutch Health Insurance Executive Board; 2004. In Dutch.
  • 32
    Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002; 20: 44354.
  • 33
    Van den Hout WB, Tijhuis GJ, Hazes JM, Breedveld FC, Vliet Vlieland TP. Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Ann Rheum Dis 2003; 62: 30815.
  • 34
    Van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care: the Health and Labor Questionnaire. Int J Technol Assess Health Care 1996; 12: 40515.
  • 35
    Torrance GW. Measurement of health state utilities for economic appraisal [review]. J Health Econ 1986; 5: 130.
  • 36
    The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199208.
  • 37
    Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095108.
  • 38
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 21727.
  • 39
    Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21: 27192.
  • 40
    Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, Haes HJ. The 'utility' of the visual analog scale in medical decision making and technology assessment: is it an alternative to the time trade-off? Int J Technol Assess Health Care 1996; 12: 2918.
  • 41
    Tijhuis GJ, Jansen SJ, Stiggelbout AM, Zwinderman AH, Hazes JM, Vlieland TP. Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis. Ann Rheum Dis 2000; 59: 8927.
  • 42
    Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, et al. Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002; 11: 27382.
  • 43
    Twisk J, de Vente W. Attrition in longitudinal studies: how to deal with missing data. J Clin Epidemiol 2002; 55: 32937.
  • 44
    Desgagne A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998; 13: 48797.